Renin Angiotensin System Side Effects | Medical Algorithm

Evaluation

Are you evaluating a patient with acute myeloid leukemia?

Yes

Does the patient have unexplained hypokalemia?

Yes

Does PCR on bone marrow blasts show overexpression of renin and/or angiotensinogen at diagnosis?

Yes

Does flow cytometry on the bone marrow show over-expression of CD143 on blast cells?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of findings associated with over-expression of the RAS

Is there evidence of RAS over-expression in this patient?

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Severity, Prognosis, Stage
Complications
- Prognostic Index of Breems et al (European Prognostic Score) for an Adult Patient with Acute Myelogenous Leukemia (AML) in the First Relapse
- Prognostic Score of Haferlach et al for Acute Myeloid Leukemia (AML)

Therapy

Selection

Specialty

Hematology Oncology

Objective

laboratory tests

ICD-10

C92.0 - Acute myeloblastic leukaemia [AML]

Acute Myeloid Leukemia | Activity of Renin-Angiotensin System (RAS)

Purpose: To evaluate a patient with acute myeloid leukemia (AML) for overexpression of the renin-angiotensin system (RAS).